在动脉样硬化中基于介质干细胞的再生疗法:最新的审查
Hanie Mahaki1, Mohsen Sheykhhasan2, Hamid Reza Rahimi1,3
1Vascular and Endovascular Surgery Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.
Current cardiology reports
|December 29, 2025
概括
介质干细胞 (MSC) 疗法通过减少炎症和修复血管,对动脉样硬化有很大的希望. 进一步的临床试验至关重要,以确认这些再生治疗的安全性和有效性.
科学领域:
- 再生医学是一种再生医学.
- 心血管研究研究心血管研究
- 干细胞生物学 干细胞生物学
背景情况:
- 动脉样硬化是一种慢性炎症性疾病,其特点是动脉中积聚斑块.
- 目前动脉样硬化治疗的重点是风险因素管理和斑块稳定,再生选择有限.
研究的目的:
- 为了提供一个更新的介绍介质干细胞 (MSC) 基础的再生疗法用于动脉样硬化.
- 探索应用MSC治疗动脉样硬化的作用机制,最近的进展和挑战.
主要方法:
- 本综述综合了最近关于动脉样硬化中的MSCs的临床前和临床研究的发现.
- 它检查了各种MSC应用策略,包括直接管理和基于生物材料的输送系统.
主要成果:
- MSCs在调节炎症,促进血管修复和减少动脉样硬化斑块形成方面表现出潜力.
- 新的方法,如低氧条件的MSC和组合疗法,显示出有希望的临床前结果.
- 现有研究强调了MSC在临床前动脉样硬化模型中的治疗能力.
结论:
- 基于MSC的疗法代表了治疗动脉样硬化的有希望的途径.
- 进一步的临床试验对于确定MSC治疗的安全性和有效性至关重要.
- 未来的研究应该优化MSC输送,并研究动脉样硬化患者的长期结果.
相关概念视频
01:19Mesenchymal Stem Cells
5.4K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.4K
01:21Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K